Related Experiment Videos
Cancer symptom clusters: clinical and research methodology
Jordanka Kirkova1, Aynur Aktas, Declan Walsh
1Taussig Cancer Institute, Department of Solid Tumor Oncology, Cleveland Clinic, Cleveland, Ohio 44195, USA.
Introduction:
Patients with cancer experience multiple symptoms that frequently appear in groups or clusters. We conducted a comprehensive clinical review of cancer symptom cluster studies to identify common symptom clusters (SC), explore their clinical relevance, and examine their research importance.
Methods:
Published studies and review articles on cancer SC were obtained through a literature search. We identified 65 reports. These varied in assessment instruments, outcomes, design, population characteristics, and study methods.
Results:
Two main approaches to symptom cluster identification were found: clinical and statistical. Clinically determined SC were based upon observations of symptom co-occurrence, associations, or interrelations. These included fatigue-pain, fatigue-insomnia, fatigue-insomnia-pain, depression-fatigue, and depression-pain. They were analyzed by multivariate analysis. They had low to moderate statistical correlations. Disease- or treatment-related SC were influenced by primary cancer site, disease stage, or antitumor treatment. SC determined by statistical analysis were identified by factor and cluster analysis through nonrandom symptom distribution. Nausea-vomiting, anxiety-depression, fatigue-drowsiness, and pain-constipation consistently clustered by either or both of these statistical methods. The individual symptoms of pain, insomnia, and fatigue often appeared in different clusters. A consensus about standard criteria and methodological techniques for cluster analysis should be established.
Conclusions:
Several important cancer SC have been identified. Nausea-vomiting, anxiety-depression, and dyspnea-cough clusters were consistently reported. The techniques of symptom cluster identification remain a research tool, but one with considerable potential clinical importance. Further research should validate our analytical techniques, and expand our knowledge about SC and their clinical importance.
Related Concept Videos
Cancer Survival Analysis
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Hazard Ratio
For example, in a clinical trial evaluating a...
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...